Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(14%)
Results Posted
33%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
6
86%
Ph early_phase_1
1
14%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Not yet recruiting2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
75.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (14.3%)
N/A6 (85.7%)

Trials by Status

recruiting114%
not_yet_recruiting229%
terminated114%
completed343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7